Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1135268.RAfglIq5jdBGTq12cjlnl6zNOgnCTA3BEsPJeI1n3Z6W0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1135268.RAfglIq5jdBGTq12cjlnl6zNOgnCTA3BEsPJeI1n3Z6W0130_assertion type Assertion NP1135268.RAfglIq5jdBGTq12cjlnl6zNOgnCTA3BEsPJeI1n3Z6W0130_head.
- NP1135268.RAfglIq5jdBGTq12cjlnl6zNOgnCTA3BEsPJeI1n3Z6W0130_assertion description "[We believe that RIP3 and MLKL could represent attractive targets for the management of human IBD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1135268.RAfglIq5jdBGTq12cjlnl6zNOgnCTA3BEsPJeI1n3Z6W0130_provenance.
- NP1135268.RAfglIq5jdBGTq12cjlnl6zNOgnCTA3BEsPJeI1n3Z6W0130_assertion evidence source_evidence_literature NP1135268.RAfglIq5jdBGTq12cjlnl6zNOgnCTA3BEsPJeI1n3Z6W0130_provenance.
- NP1135268.RAfglIq5jdBGTq12cjlnl6zNOgnCTA3BEsPJeI1n3Z6W0130_assertion SIO_000772 24322838 NP1135268.RAfglIq5jdBGTq12cjlnl6zNOgnCTA3BEsPJeI1n3Z6W0130_provenance.
- NP1135268.RAfglIq5jdBGTq12cjlnl6zNOgnCTA3BEsPJeI1n3Z6W0130_assertion wasDerivedFrom befree-2016 NP1135268.RAfglIq5jdBGTq12cjlnl6zNOgnCTA3BEsPJeI1n3Z6W0130_provenance.
- NP1135268.RAfglIq5jdBGTq12cjlnl6zNOgnCTA3BEsPJeI1n3Z6W0130_assertion wasGeneratedBy ECO_0000203 NP1135268.RAfglIq5jdBGTq12cjlnl6zNOgnCTA3BEsPJeI1n3Z6W0130_provenance.